RT Book, Section A1 Papadakis, Maxine A. A1 McPhee, Stephen J. A1 Rabow, Michael W. A1 McQuaid, Kenneth R. SR Print(0) ID 1183884685 T1 Breast Disorders T2 Current Medical Diagnosis & Treatment 2022 YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264269389 LK accessmedicine.mhmedical.com/content.aspx?aid=1183884685 RD 2024/04/25 AB In 2020, the FDA approved neratinib (in combination with capecitabine) and margetuximab, a monoclonal antibody similar to trastuzumab that is designed to improve the antibody dependent cellular cytotoxicity mechanism of action when used with chemotherapy.